Skip to content
OpenCapital
Get started

Cytosorbents CTSO Q4 2025 Annual earnings

Reported March 25, 2026 · After market close

Revenue$9.2MMiss by $546.0KDiluted EPS-$0.09Miss by $0.04
Revenue estimate$9.8M
EPS estimate-$0.05

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$9.4M
EPS estimate-$0.05

Versus estimates

Revenue

Q1 2026$8.9MMiss by $536.0K
Q4 2025$9.2MMiss by $546.0K
Q3 2025$9.5MBeat by $270.0KQ2 2025$9.6MBeat by $395.3KQ1 2025$8.7MMiss by $280.3KQ4 2024$6.5MMiss by $3.6M

Diluted EPS

Q1 2026-$0.08Miss by $0.02
Q4 2025-$0.09Miss by $0.04
Q3 2025-$0.04Beat by $0.02Q2 2025-$0.05Beat by $0.02Q1 2025-$0.06Beat by $0.02Q4 2024-$0.03Beat by $0.04

Ask the moment Cytosorbents reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cytosorbents report Q4 2025 earnings?
Cytosorbents (CTSO) reported Q4 2025 earnings on March 25, 2026 after market close.
What were Cytosorbents's Q4 2025 revenue and EPS?
Cytosorbents reported revenue of $9.2M and diluted EPS of $-0.09 for Q4 2025.
Did Cytosorbents beat estimates in Q4 2025?
Revenue missed the consensus estimate of $9.8M by $546.0K. EPS missed the consensus estimate of $-0.05 by $0.04.
How did Cytosorbents's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 41.6% from $6.5M a year earlier and diluted EPS declined 200.0% from $-0.03.
Where can I find Cytosorbents's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000929638-26-001150) and the 10-K periodic report (0001104659-26-036451) directly on SEC EDGAR. The filing index links above go to sec.gov.